Objective-To establish identifiable prenatal factors in fetal heart block which might predict death in utero, the need for intervention, or the probability of pacemaker requirement. Setting-Tertiary referral unit for fetal echocardiography. Subjects-36 fetuses with congenital complete heart block and structurally normal hearts identified between 1980 and 1993. Methods-Maternal anti-Ro antibody status was documented. Prenatal variables examined included absolute heart (ventricular) rate, change in rate, and development of hydrops fetalis. Postnatally, heart rate, need for pacing, and the indications for pacing were detailed. Results-Of the total of 36 patients, there are 24 survivors; 11 are paced. Of those fetuses which died, two were electively aborted for severe hydrops, seven died in utero, two were immediate postnatal deaths, and one was an unrelated infant death. The trend was for the heart rate to decrease during fetal life and postnatally. Fetuses with deteriorating cardiac function did not always show the lowest heart rates. Bradycardia of less than 55 beats/min in early pregnancy or rapid decrease in heart rate prenatally were poor prognostic signs. Hydrops was also associated with bad outcome, 10 out of the 12 hydropic fetuses dying (83%). Of 10 fetuses presenting with a heart rate above 60/min, nine survived of whom three required pacing. Of seven presenting with heart rates of S0/min or less, only three survived and two of these required pacing. Of the two fetuses with negative maternal anti-Ro antibody status one died in utero and one required heart transplantation after pacemaker insertion. Conclusions-Isolated complete heart block identified in fetal life does not always have a good prognosis. An individual heart rate does not accurately predict the outcome in utero or the need for postnatal pacing. Regular, careful monitoring during pregnancy is required in order to optimise care and timing of any interventions.
hearts identified between 1980 and 1993. Methods-Maternal anti-Ro antibody status was documented. Prenatal variables examined included absolute heart (ventricular) rate, change in rate, and development of hydrops fetalis. Postnatally, heart rate, need for pacing, and the indications for pacing were detailed. Results-Of the total of 36 patients, there are 24 survivors; 11 are paced. Of those fetuses which died, two were electively aborted for severe hydrops, seven died in utero, two were immediate postnatal deaths, and one was an unrelated infant death. The trend was for the heart rate to decrease during fetal life and postnatally. Fetuses with deteriorating cardiac function did not always show the lowest heart rates. Bradycardia of less than 55 beats/min in early pregnancy or rapid decrease in heart rate prenatally were poor prognostic signs. Hydrops was also associated with bad outcome, 10 out of the 12 hydropic fetuses dying (83%). Of 10 fetuses presenting with a heart rate above 60/min, nine survived of whom three required pacing. Of seven presenting with heart rates of S0/min or less, only three survived and two of these required pacing. Of the two fetuses with negative maternal anti-Ro antibody status one died in utero and one required heart transplantation after pacemaker insertion. Conclusions An association between fetal isolated complete heart block and maternal connective tissue disease has been described. 78 Pathological changes have been directly related to circulating maternal anti-Ro antibodies, even in the absence of clinical disease. 9 Histologically there is fibrous replacement of the conducting tissue.' ,1
In 1988 we reported our clinical experience of complete heart block in the fetus: 16 cases with isolated complete heart block and 21 of heart block with structural heart disease (17 with left atrial isomerism). Fetal outcome with isolated heart block was good, compared with a mortality of 85% in those with structural heart disease.'2 It has since become evident that cardiac failure and death can occur in isolated heart block.'"'5 This natural history has led to interventions including premature delivery,'6 administration of inotropes,'7 steroids and/or plasmapheresis'8 and transabdominal pacing of the fetus. '9 Since 1980, we have diagnosed isolated complete heart block in 36 fetuses, including one set of twins. An analysis of the outcome of the group-the largest single centre series to date-was undertaken in order to establish any risk factors identifiable prenatally which might predict in utero death or pacemaker requirement. These would be relevant for prenatal intervention, site of delivery, timing and management of labour, and parental counselling.
Methods
Between 1980 and January 1994, 36 fetuses with isolated congenital complete heart block were identified from 10 600 referrals for fetal echocardiography. The reviewed more frequently, four to six weekly initially, but two weekly if any signs of cardiac failure were noted. Postnatal electrocardiography confirmed the diagnosis in all live deliveries. The heart rates were recorded by clinical observation or by 12-lead electrocardiogram and by ambulatory electrocardiographic analysis. The age and criteria used for pacing were recorded. Details in all surviving patients were obtained from the relevant paediatric cardiology centre.
Necropsy analysis of the cardiac structure and the histology of the conducting tissue were sought where possible.
The results were assessed for significance using the %2 test and significance was assumed atP < 005. Weeks after estimated time Years after birth of conception Figure 1 Kaplan-Meyer survival curve for congenital complete heart block detected prenatally. This curve shows that the major attrition ofpatients in the prenatal series is antenatal. The non-cardiac death has been excluded. There was no fetal loss before 27 weeks gestation. Numbers in parenthesis are the numbers ofpatients alive at the follow up interval. One patient who had a satisfactory heart rate on 24 h monitoring had a cardiac arrest at 4 months and was paced after resuscitation. She now has a severe neurological handicap. Retrospective analysis showed a prolonged QT interval of 648 ms and heart rate 60/min with no ventricular arrhythmia noted.
One of the survivors had negative maternal anti-Ro status. This patient was paced but required cardiac transplantation for cardiomyopathy. The excised heart specimen showed interruption of the bundle of His. Of the 24 surviving patients with isolated complete heart block diagnosed in utero, 11 (46%) have required pacing so far. Maximum follow up duration is 12 years, minimum six months, mean 5j years. Table 2 outlines the age and indication for pacing.
IN UTERO HEART RATE
One patient had a normal heart rate at 18 weeks gestation which evolved into complete heart block by 22 weeks. Otherwise, heart rate at presentation varied between 45 and 80 beats/min, with overall a higher rate earlier in gestation. Fetal heart rate increased with activity (fig 2) . Most fetuses showed no significant change in heart rate with advancing gestation, but of 25 who had more than one examination, nine showed a decrease of more than 5 beats/min. Of these, five died in utero (P < 0.001), two showed an increased rate, and one of these fetuses subsequently died (fig 3) . Heart rate at presentation was 51 (SD 6 8) beats/min for those who died, 53 beats/min in those who survived but required pacing, and 64 (8 3) beats/min in those survivors not requiring pacing (fig 4) . However, the difference between the heart rate at presentation of infants paced but alive and those who died was not significant, and there was no significant difference between rates at presentation of the paced versus non-paced survivors.
Of 10 fetuses presenting with a heart rate above 60/min, nine survived (90%) and only three have required pacing so far (33% of survivors). Meanwhile, of seven presenting with a rate of 50 or less, only three survived (42%) and two of these three have required pacing (table 3) . A presenting heart rate less than 55/min before 28 weeks gestation was associated with death in five and permanent pacemaker in the other one of six fetuses. This reached statistical significance on X2 analysis (P < 0-001; fig 2) . Discussion Isolated congenital complete heart block in the fetus has been well described. The association with maternal anti-Ro antibody has also been 192 N. 1415 In our current series the greatest attrition occurred prenatally, heart failure affecting 12 of our 36 cases. Perinatal loss occurred in 10 of these cases, which is comparable to hydropic deaths in all four of 26 cases in a combined report from three centres. '5 We have not shown an absolute relation between the initial ventricular rate and outcome but agree with other investigators that rates below 55/min during early pregnancy have a worse prognosis.'3 15 However the wide scatter makes it difficult to give a prognosis in any one case (fig 2) . Our findings are comparable with the postnatal series without structural cardiac defects reported by Sholler and Walsh.20 The majority (56%) of fetuses maintained the same rate. In 36% heart rate fell with advancing gestation, and where it decreased by 5 beats/min or more the mortality was 55%. Two patients in the group showed a small increase in heart rate, indicating some variability with activity already documented in children with heart block.2' One of these fetuses died in utero, which was perhaps surprising as the ability to increase heart rate with exercise is associated with favourable outcome postnatally.22 23 Successful maternal prophylaxis has been claimed for steroids and plasmapheresis in individual cases. However, as the recurrence risk is only 8-20%, treatment efficacy has not been established.9 Prenatal intervention in the hydropic affected fetus has also been tried. Three such patients were given steroids with no success, but we have had success with salbutamol in one patient in our unit. '7 In one report direct intrauterine pacing was technically successful for some hours before fetal death. '9 Long term problems would be potential sepsis, displacement of the wire, or fetal limb damage from it. Future devices might be implanted under the fetal skin.
The major attrition in our series is prenatally and immediately postnatally in those delivered prematurely for worsening hydrops. All but one was hydropic.'3 There has been no mortality related to heart block beyond the neonatal period.
The decreasing heart rate seen in serial prenatal scans often continued into postnatal life, perhaps because of fibrosis extending to the bundle of His."
Endocardial pacing in childhood is now technically reliable although not undertaken without clear indications. Permanent pacing was required in 11 patients, 55% of whom were symptomatic. Asymptomatic cases did not have absolute indications for pacing, but low heart rates and either long QT or exit block with pauses were the basis of the decision to pace in our unit and other paediatric cardiology centres. The combination of a low heart rate with long QT interval had a significantly poor outcome in a postnatal multicentre 23 24 series.
The patient who was paced only after cardiac arrest illustrates the importance of assessment of QT interval. 25 The two cases which showed repeated negative maternal anti-Ro antibody both had poor outcomes. One died prenatally and the other required cardiac transplantation-both hearts showing interruption of the bundle of His of a familial type. This may have represented a new mutation or incomplete family history.
CONCLUSIONS
Reviewing our series of patients with isolated complete heart block we found a heart rate below 55 beats/min in early pregnancy, or one which drops below 50 beats/min, is associated with greater likelihood of poor outcome. The likelihood of requiring early pacemaker insertion, however, cannot be predicted with certainty from the prenatal heart rate. These patients should therefore be monitored at frequent intervals, every one to two weeks, or monthly for those at lower risk, searching particularly for early evidence of cardiac decompensation. In this way the optimum decision would be made with respect to possible antenatal treatment, early delivery, perinatal monitoring without cardiotocographic assistance, and management of the hydropic neonate.
Rheumatic fever: pathogenesis revealed
Generations of medical students have been inconsist taught concepts about the pathogenesis of tological rheumatic fever which have great appeal. The age and t concept of "molecular mimicry" lays down in the tisE that certain components of the wall of certain cells fron strains of steptococci fortuitously show close rheumati molecular similarity with connective tissue and bact4 components of heart valves and myocardium the heart and that antibodies produced against the bac-importan terial antigen cross react against the heart, causing damage. The theory always had -encies. The Aschoff body has no hisfeatures that suggest humoral dambound gamma globulin is not present sues. The present study shows that T n the hearts of subjects who have had ic fever can recognise both cardiac erial wall antigens and the damage to t is probably cell based-a small but it change in thinking M J DAVIES ABSTRACTS IN CARDIOLOGY
